Ayurvedic Supplements

Ashwagandha, shilajit, brahmi, moringa, shatavari, triphala — India's traditional plant pharmacopoeia is now being subjected to randomised controlled trials, systematic reviews, and pharmacokinetic studies. The results are more interesting than either camp wants to admit. Some adaptogens are holding up well against the scrutiny. Others are riding brand recognition far ahead of the evidence.

The challenge with Ayurvedic supplements is threefold: standardisation is inconsistent, clinical trials often use extracts at doses traditional practice would not recognise, and the active compound picture is genuinely complex. These guides separate what has passed peer-reviewed scrutiny from what remains traditional medicine, covering dosing, bioavailability, drug interactions, and what to look for on a supplement label.

Reading an Ayurvedic supplement label requires specific knowledge. For ashwagandha, extract standardisation matters enormously: KSM-66 and Sensoril are the two most-studied root extracts, standardised to specific withanolide concentrations and backed by independent clinical trials. A generic "ashwagandha extract" without a branded extract designation or withanolide percentage on the label is likely to be inconsistently potent. The same logic applies to brahmi (bacosides ≥40%), boswellia (AKBA ≥30%), and curcumin (piperine co-administration or phospholipid complex for bioavailability). Capsule or tablet form is generally preferable to raw churna for supplement use — the dose is controlled and the preparation is standardised.

Drug interactions are an underappreciated risk in this space. Ashwagandha has thyroid-stimulating effects — potentially beneficial for subclinical hypothyroidism but potentially problematic in combination with levothyroxine, which is extremely commonly prescribed in India. Triphala has mild blood-thinning properties that interact with anticoagulants. Guggul interacts with statins. Shatavari has oestrogen-modulating activity relevant for women on hormonal medications. These guides flag significant known interactions in each supplement profile.

The regulatory landscape for Ayurvedic supplements in India is complex. Classical formulations under the Drugs and Cosmetics Act fall under strict Ayush Ministry oversight. Dietary supplements (nutraceuticals) are regulated by FSSAI under Food Safety and Standards Regulations. For consumers, FSSAI approval is a baseline quality signal, not a guarantee of efficacy. Third-party testing from NABL-certified labs provides the best quality assurance available. These guides only reference products and ingredients where clinical trial evidence exists at tested doses — not on the basis of traditional use alone.